Texas Attorney General Paxton is filing a lawsuit against the makers of Tylenol, asserting the corporations withheld safety concerns that the drug created to pediatric brain development.
The lawsuit comes thirty days after President Donald Trump promoted an unproven link between taking Tylenol - alternatively called acetaminophen - throughout gestation and autism spectrum disorder in young ones.
The attorney general is suing J&J, which once produced the medication, the only pain reliever recommended for women during pregnancy, and Kenvue, which now manufacturers it.
In a official comment, he said they "deceived the public by making money from pain and marketing drugs ignoring the risks."
Kenvue asserts there is no credible evidence connecting Tylenol to autism spectrum disorder.
"These manufacturers lied for decades, deliberately risking numerous people to boost earnings," Paxton, from the Republican party, stated.
The company said in a statement that it was "deeply concerned by the dissemination of inaccurate information on the security of paracetamol and the potential impact that could have on the welfare of US mothers and children."
On its online platform, Kenvue also stated it had "regularly reviewed the applicable studies and there is lacking reliable evidence that indicates a proven link between taking acetaminophen and autism spectrum disorder."
Associations representing medical professionals and healthcare providers concur.
The American College of Obstetricians and Gynecologists has said paracetamol - the primary component in acetaminophen - is one of the few options for pregnant women to address pain and elevated temperature, which can create serious health risks if left untreated.
"In over twenty years of studies on the utilization of acetaminophen in gestation, no reliable research has successfully concluded that the consumption of acetaminophen in any trimester of gestation leads to brain development issues in children," the group said.
This legal action cites current declarations from the Trump administration in asserting the drug is potentially dangerous.
In recent weeks, Trump caused concern from medical authorities when he advised pregnant women to "fight like hell" not to take acetaminophen when unwell.
The FDA then issued a notice that physicians should consider limiting the use of Tylenol, while also mentioning that "a causal relationship" between the medication and autism in young ones has remains unverified.
Health Secretary Kennedy, who manages the Food and Drug Administration, had pledged in April to conduct "comprehensive study program" that would identify the source of autism spectrum disorder in a limited time.
But authorities warned that discovering a unique factor of autism spectrum disorder - thought by researchers to be the result of a complex mix of inherited and environmental factors - would be difficult.
Autism spectrum disorder is a form of enduring cognitive variation and impairment that influences how persons perceive and engage with the surroundings, and is identified using medical professional evaluations.
In his legal document, the attorney general - aligned with the former president who is running for the Senate - asserts the manufacturer and J&J "willfully ignored and sought to suppress the evidence" around paracetamol and autism spectrum disorder.
This legal action attempts to require the firms "eliminate any commercial messaging" that asserts Tylenol is reliable for women during pregnancy.
This legal action mirrors the complaints of a assembly of mothers and fathers of minors with autism and ADHD who took legal action against the manufacturers of acetaminophen in two years ago.
The court threw out the lawsuit, stating investigations from the parents' expert witnesses was inconclusive.
A seasoned traveler and writer with a passion for uncovering hidden gems and sharing transformative journeys across continents.